SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-083356
Filing Date
2024-04-01
Accepted
2024-04-01 16:06:34
Documents
13
Period of Report
2024-03-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d818300d8k.htm   iXBRL 8-K 24562
  Complete submission text file 0001193125-24-083356.txt   146182

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mnov-20240326.xsd EX-101.SCH 2859
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20240326_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20240326_pre.xml EX-101.PRE 11267
17 EXTRACTED XBRL INSTANCE DOCUMENT d818300d8k_htm.xml XML 3708
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33185 | Film No.: 24809167
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)